Myasthenia Gravis: Understanding the Disease, the Treatment, and the Medicines to Avoid

Imagine waking up one morning with eyelids too heavy to fully open. By afternoon, your voice sounds nasal and chewing through a meal leaves you exhausted. By evening, you feel almost normal again. The next day, it starts over.

This fluctuating, activity-dependent weakness — worse with effort, better with rest — is the hallmark of myasthenia gravis (MG). It is one of the most misunderstood conditions in neurology. In India, it is frequently mistaken for fatigue, thyroid problems, or cervical spondylosis for months or even years before the correct diagnosis is made.

More than almost any other chronic condition, MG demands careful medication management. The treatment itself is complex, but what makes MG particularly dangerous is a long list of common medicines — antibiotics, antacids, eye drops, heart medicines — that can silently worsen the disease or trigger a life-threatening crisis in someone who is otherwise stable.

What happens in the body

Normally, when your brain wants a muscle to move, it sends a signal down a nerve. At the nerve ending, a chemical called acetylcholine is released, crosses a tiny gap, and attaches to receptors on the muscle to trigger movement. In myasthenia gravis, the immune system produces antibodies that attack and block these acetylcholine receptors. Fewer receptors mean weaker signals, and weaker signals mean weaker muscles.

The weakness is not constant because the nerve keeps releasing acetylcholine. But the more you use a muscle, the more the available acetylcholine is depleted, and the weaker the muscle gets. Rest allows it to build up again, which is why patients often feel better in the morning and weaker as the day goes on.

In most patients, the antibodies target the acetylcholine receptor (AChR). In a smaller group, they target a protein called MuSK (muscle-specific kinase). A third group is described as seronegative — the antibodies are present but current tests cannot detect them. This matters because treatment response can differ between these groups.

Symptoms to look out for

MG can affect any voluntary muscle, but certain muscles are involved far more commonly than others. The pattern of weakness is characteristic: it worsens with repeated use and improves with rest.

MG does not cause pain, numbness, tingling, or problems with bladder or bowel function. If those symptoms are present, another diagnosis should be considered.

How MG is diagnosed

Diagnosis is made by a neurologist and involves a combination of clinical assessment, blood tests, and electrical studies. The key investigations are:

The medicines used to treat MG

Treatment has two goals: relieve symptoms in the short term, and suppress the underlying autoimmune process in the long term. The two are usually managed together.

Medicines that can worsen MG — the critical list

This is the section that matters most from a medication safety perspective, and the one most often overlooked in routine care. Many common medicines prescribed for entirely different conditions can exacerbate MG or precipitate a crisis. Patients must be aware of this risk every time a new medicine is prescribed.

Myasthenic crisis: know when to go to hospital

A myasthenic crisis is a medical emergency defined by respiratory muscle weakness severe enough to require ventilatory support. It can develop over hours or days and is triggered by infection, surgery, missed medication, or the wrong medicine.

Living with MG

Unlike many chronic conditions where missing a dose is inconvenient but not immediately dangerous, pyridostigmine is time-sensitive. Missing a dose means the acetylcholine at the neuromuscular junction is not being protected, and weakness returns quickly. Time your doses around your day.

Why medication review matters in MG

Patients with MG are, by necessity, on multiple medicines. Often a symptomatic agent, one or two immunosuppressants, and additional medicines to manage the side effects of those immunosuppressants (calcium and vitamin D for bone protection during steroid use, for example). Many will also have separate conditions — hypertension, diabetes, thyroid disorders — with their own medications.

In this context, a full medication review by a clinical pharmacist is a practical safeguard, not a luxury. The aim is to ensure that every medicine being taken is necessary, appropriately dosed, and compatible with the MG diagnosis. It is also an opportunity to flag anything in the regimen that carries MG-specific risk and to review medicines that may have been continued out of habit long after they were needed.

If you or a family member has been diagnosed with MG and would like a structured review of your medicines, that is exactly the kind of session Dr D's MedCare offers.